期刊文献+

两种人乳头瘤病毒分型检测方法的比较 被引量:3

Comparison of two methods in genotyping and detecting human papillomavirus
下载PDF
导出
摘要 目的通过比较PCR联合地高辛标记探针杂交法与实时荧光定量PCR法检测宫颈液标本中人乳头瘤病毒(HPV)感染的一致性,评价PCR联合地高辛标记探针杂交法的临床应用价值。方法将4型HPV(16、51、54和56)探针3′端加尾地高辛标记,检测标记探针的灵敏度和特异性。收集63例第二代杂交捕获(HC-Ⅱ)阳性和18例HC-Ⅱ阴性的宫颈液标本,采用HPV通用引物MY11/09对所有标本L1区基因序列进行PCR扩增,利用地高辛标记探针杂交法对PCR产物进行检测分型;同时利用实时荧光定量PCR对这81例标本进行检测,将两者的检测结果进行比较。结果地高辛标记探针杂交法检测出HC-Ⅱ阳性标本中HPV-16型40例,HPV-51型2例,HPV-56型2例,分别占HC-Ⅱ阳性标本的63.5%、3.2%和3.2%,HC-Ⅱ阴性标本中检测出HPV-16型1例;实时荧光定量PCR法检测出HC-Ⅱ阳性标本中HPV-16型39例,HPV-51型2例,HPV-56型2例,占HC-Ⅱ阳性标本的61.9%、3.2%和3.2%,HC-Ⅱ阴性标本中检测出HPV-16型1例;重复性检测显示两种方法检测4型HPV感染的变异系数(CV)为0-1.45%和0-1.50%,检测标本中4型感染的符合率为97.5%-100%。结论PCR联合地高辛标记探针杂交法具有较好的灵敏度和特异性,可能对于临床HPV分型检测有应用价值。 Objective To evaluate the clinical application value of PCR combined with digoxin labeled probe hybridization by comparing detection results of digoxin labeled probe hybridization with real-time PCR for human papillomavirus(HPV) infection in cervix fluid specimens. Methods Type specific probes for 4 subtypes HPV(16,51,54 and 56) were labeled by incorporating a digoxin labeled oligonucleotides tail at their 3'-end,then sensitivity and specificity of the digoxin-labeled probes were detected.Sixty-three positive and 18 negative cervix fluid specimens identified by hybrid capture Ⅱ(HC-Ⅱ) were collected.HPV L1 gene of all specimens was amplified by primers MY11/09 mediated PCR.PCR products were detected by probes hybridization,and the 81 specimens were detected by real-time PCR simultaneously. ResultsAmong 63 HPV positive specimens identified by HC-Ⅱ,HPV-16 was detected in 40 cases,HPV-51 in 2 cases and HPV-56 in 2 cases for hybridization method.The positive rates of HPV-16,HPV-51 and HPV-56 were 63.5%,3.2% and 3.2%,respectively.Moreover,in 18 HPV negative specimens identified by HC-Ⅱ,HPV-16 was found in 1 case.For real-time PCR method,HPV-16 was detected in 39 cases,HPV-51 in 2 cases and HPV-56 in 2 cases.The positive rates of HPV-16,HPV51 and HPV56 were 61.9%,3.2% and 3.2%,respectively.In 18 HPV negative specimens identified by HC-Ⅱ,HPV-16 was also found in 1 case.The coincidence rates of probes hybridization and real time PCR for detecting HPV-16,HPV51,HPV-54 and HPV56 were 97.5%,100%,100% and 100%,respectively. Conclusion The PCR combined with digoxin labeled probe hybridization may be a sensitive and specific method in clinical detection of HPV specimens.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第8期962-966,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委基金(054319928)~~
关键词 人乳头瘤病毒 杂交 实时荧光定量聚合酶链反应 human papillomavirus hybridization real-time polymerase chain reaction
  • 相关文献

参考文献16

  • 1Walboomers JM,Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[ J]. J Pathol, 1999, 189(1) :12 -19.
  • 2McLachlin CM. Human papillomavirus in cervical neoplasia. Bole, risk factors, and implications [ J ]. Clin Lab Med, 2000,20 (2) : 257 - 270.
  • 3ClaveI C, Masure M, Putaud I, et al. Hybrid capture Ⅱ, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture Ⅰ and PCR results in cervical lesions [J]. J Clin Pathol, 1998, 51 (10) :737 - 740.
  • 4钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168
  • 5Kiatpongsan S, Niruthisard S, Mutirangnra A, et al. Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance [ J ]. Int J Gynecol Cancer,2006,16 ( 1 ) :262 - 265.
  • 6Lonky NM, Felix JC, Naidu YM, et al. Triage of atypical squamous cells of undetermined significance with hybrid capture Ⅱ :colposcopy and histologic human papillomavirus correlation [ J ]. Obstet Gynecol, 2003, 101(3) :481-489.
  • 7Masumoto N, Fujii T, Ishikawa M, et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women ; study of 881 outpatients [ J ]. Gynecol Oncol, 2004,94 (2) : 509 - 514.
  • 8Stanczuk GA, Kay P, Sibanda E, et al. Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix[ J]. Acta Obstet Gynecol Scand ,2003,82 (8) :762 - 766.
  • 9Kleter B, van Doom LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus[ J]. J Clin Microbiol, 1999, 37 (8) :2508 - 2517.
  • 10Papin JF,Vahrson W, Dittmer DP, et al. SYBR green-based realtime quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability[ J]. J Clin Microbiol,2004,42(4) :1511 - 1518.

二级参考文献15

  • 1Syrjanen S,Shabalova IP,Petrovichev N,et al.Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in Countries of the former Soviet Union.J Low Genit Tract Dis,2002,6:97-110.
  • 2Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87:796-802.
  • 3Vizcaino AP,Moreno V,Bosch FX,et al.International trends in incidence of cervical cancer:Ⅱ.Squamous-cell carcinoma.Int J Cancer,2000,86:429-435.
  • 4Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 5Clavel C,Masure M,Bory JP,et al.Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women.Br J Cancer,2001,84:1616-1623.
  • 6Blumenthal PD,Gaffikin L,Chirenje ZM,et al.Adjunctive testing for cervical cancer in low resource settings with visual inspection,HPV,and the Pap smear.Int J Gynaecol Obstet,2001,72:47-53.
  • 7Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.J Natl Cancer Inst,2000,92:818-825.
  • 8Saslow D,Runowicz CD,Solomon D,et al.American cancer society guideline for the early detection of cervical neoplasia and cancer.CA Cancer J Clin,2002,52:342-362.
  • 9Sherman ME,Lorincz AT,Scott DR,et al.Baseline cytology,human papillomavirus testing,and risk for cervical neoplasia:a 10-year cohort analysis.J Natl Cancer Inst,2003,95:46-52.
  • 10Belinson J,Qiao YL,Pretorius R,et al.Shanxi province cervical cancer screening study:a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.Gynecol Oncol,2001,83:439-444.

共引文献167

同被引文献33

  • 1Cox T, Cuzick J. HPV DNA testing in cervical cancer screening: From evidence to polices [J]. Gynecol 0ncol,2006, 10(3):8-11.
  • 2Ki H K, Man S Y, Yong J N, et al. Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip [ J ]. Gynecol Oncol, 2006,100 ( 1 ) : 38-43.
  • 3Munoz N, Bosch F X, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen [J]. Int J Cancer, 2004,111(2) :278-283.
  • 4唐敏,戴勇,吕晓萍,李体远.深圳市人民医院352例尖锐湿疣患者生殖道人乳头状瘤病毒基因亚型的分布及意义[J].第三军医大学学报,2007,29(21):2086-2088. 被引量:2
  • 5王鹤,乔友林.人乳头瘤病毒型别及其相关疾病[J].中国医学科学院学报,2007,29(5):678-684. 被引量:44
  • 6Ciapponi A,Bardach A,Glujovsky D,et al. Type-specific HPV prevalence in cerv'ical cancer and high-grade lesions in Latin America and the Caribbean:systematic review and meta-analysis [J]. PLoS One, 2011,6(10) : e25493.
  • 7Im SS,Wilczynski SP,Bt~rger RA,et al. Early stage cervical can- cers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion[J]. Clin Cancer Res, 2003,9(11) :4145-4150,.
  • 8Duttagupta C,Sengupta S,Roy M,et al. Oncogenic human papillo- mavirus (HPV) infection and uterine cervical cancer:a screening strategy in the perspective of rural India [J]. Eur J Cancer Prey, 2002,11 (5):447-456.
  • 9Franceschi S, The IARC comnfitment to cancer prevention:the ex- ample of papillomavirus and cervical cancer [J]. Recent Results Cancer Res, 2005,166 : 277~297.
  • 10An HJ,Cho NH,Lee SY,et al. Correlation of cervical carcinoma and precancerous lesions with human papilloraavirus (HPV) geno- types detected with the HPV DNA chip microarray method [J], Cancer, 2003,97(7) : 1672-1680.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部